Clarkston Capital Partners LLC Has $217.01 Million Stock Position in Clarivate PLC $CLVT

Clarkston Capital Partners LLC cut its stake in Clarivate PLC (NYSE:CLVT) by 2.6% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 64,972,134 shares of the company’s stock after selling 1,736,304 shares during the period. Clarivate makes up approximately 5.0% of Clarkston Capital Partners LLC’s holdings, making the stock its 3rd biggest position. Clarkston Capital Partners LLC owned 9.82% of Clarivate worth $217,007,000 as of its most recent SEC filing.

A number of other hedge funds have also recently bought and sold shares of the stock. Dimensional Fund Advisors LP boosted its holdings in Clarivate by 3.3% in the 3rd quarter. Dimensional Fund Advisors LP now owns 21,768,783 shares of the company’s stock valued at $83,373,000 after purchasing an additional 696,903 shares during the period. American Century Companies Inc. boosted its holdings in Clarivate by 20.6% in the 3rd quarter. American Century Companies Inc. now owns 9,973,797 shares of the company’s stock valued at $38,200,000 after purchasing an additional 1,706,306 shares during the period. Vanguard Group Inc. lifted its holdings in shares of Clarivate by 9.3% during the 3rd quarter. Vanguard Group Inc. now owns 8,922,585 shares of the company’s stock worth $34,173,000 after acquiring an additional 756,722 shares during the period. Geode Capital Management LLC boosted its position in shares of Clarivate by 1.1% during the 4th quarter. Geode Capital Management LLC now owns 7,048,518 shares of the company’s stock valued at $23,549,000 after acquiring an additional 78,367 shares in the last quarter. Finally, Balyasny Asset Management L.P. boosted its position in shares of Clarivate by 827.6% during the 3rd quarter. Balyasny Asset Management L.P. now owns 4,882,593 shares of the company’s stock valued at $18,700,000 after acquiring an additional 4,356,232 shares in the last quarter. 85.72% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several analysts have recently weighed in on the stock. Barclays decreased their target price on shares of Clarivate from $4.00 to $2.40 and set an “underweight” rating on the stock in a research report on Wednesday, February 25th. Citigroup decreased their target price on shares of Clarivate from $4.25 to $2.80 and set a “neutral” rating on the stock in a research report on Wednesday, March 4th. Wall Street Zen upgraded shares of Clarivate from a “hold” rating to a “buy” rating in a research report on Saturday, May 2nd. Royal Bank Of Canada decreased their target price on shares of Clarivate from $5.00 to $3.00 and set a “sector perform” rating on the stock in a research report on Wednesday, February 25th. Finally, Weiss Ratings reiterated a “sell (e+)” rating on shares of Clarivate in a research report on Friday, March 27th. Five analysts have rated the stock with a Hold rating and three have given a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Reduce” and an average price target of $3.22.

Clarivate Trading Up 0.3%

Shares of CLVT stock opened at $2.21 on Friday. Clarivate PLC has a 12-month low of $1.66 and a 12-month high of $4.77. The company has a market capitalization of $1.41 billion, a P/E ratio of -10.50 and a beta of 1.36. The firm has a 50-day moving average price of $2.52 and a 200 day moving average price of $2.74. The company has a quick ratio of 0.84, a current ratio of 0.84 and a debt-to-equity ratio of 0.89.

Clarivate (NYSE:CLVT) last announced its quarterly earnings results on Wednesday, April 29th. The company reported $0.18 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.14 by $0.04. Clarivate had a negative net margin of 5.61% and a positive return on equity of 8.82%. The firm had revenue of $585.50 million during the quarter, compared to the consensus estimate of $569.50 million. During the same period last year, the firm posted $0.14 EPS. The firm’s quarterly revenue was down 1.4% on a year-over-year basis. Clarivate has set its FY 2026 guidance at 0.700-0.800 EPS. Research analysts forecast that Clarivate PLC will post 0.65 earnings per share for the current fiscal year.

About Clarivate

Clarivate plc is a global information and analytics company that provides insights and workflow solutions to accelerate the pace of innovation. The company delivers proprietary data, analytics, and expertise to support research and development in the life sciences, intellectual property management, academic institutions, government agencies, and corporations. Its core offerings include citation and patent databases, drug pipeline analytics, trademark research tools, regulatory compliance solutions, and market intelligence platforms.

Originally part of Thomson Reuters’ Intellectual Property & Science division, Clarivate was established as an independent entity in 2016 following a spin-off transaction.